On the upside, 21,500 will be an immediate hurdle for the Nifty 50, while 20-DMA round 21,700 will remain a key challenge.
Hot Stocks: Zydus, Anand Rathi Wealth, Global Health may deliver in double digits on January 24, 2024 at 12:33 am
On the upside, 21,500 will be an immediate hurdle for the Nifty 50, while 20-DMA round 21,700 will remain a key challenge.
Sun Pharmaceutical Industries formed strong bullish candlestick pattern on the daily timeframe with healthy volumes, despite sharp market correction. The stock traded above all key moving averages.
With climate change affecting everything from household finances to electric grids, the profession is increasingly focused on how society can mitigate carbon emissions and cope with their impact.
The options data indicates that the Nifty may face resistance at 21,300-21,500 on the higher side, with immediate support at 21,000
Sharp selling in frontline banks, FMCG and metals put pressure on the Nifty and the Sensex. All sectoral indices except pharma ended in the red
Rallis India Q3 earnings: The agrochemical company’s revenue, however, was down 5 percent at Rs 598 crore
In today#39;s edition of Moneycontrol Pro Panorama: Ayodhya impact on general elections in the South, new budget schemes can unlock tourism potential, Middle-East is now a powder keg waiting to explode, budget allotment for science to make a big bang, and more
Biggest losers on the Nifty were IndusInd Bank, Coal India, ONGC, Adani Ports and SBI Life Insurance, while gainers were Cipla, Sun Pharma, Bharti Airtel, ICICI Bank and Hero MotoCorp
VST Industries reported nearly 6 percent on-year growth in revenue from operations to Rs 468.42 crore for Q3FY24.
The company also unveiled the Maverick 440 at its Centre of Innovation and Technology (CIT) in Jaipur